Online Oncology Second Opinion, Regenerative Medicine Advisory & Complex Case Review
Independent, structured medical advisory for complex cancer cases, regenerative medicine evaluations, advanced biomarker and genomic interpretation, and clinical trial eligibility support — delivered remotely worldwide.
The goal is simple: more clarity, fewer unknowns, and a documented plan you can discuss calmly with your treating team.
Newly diagnosed cancer patients facing complex treatment choices and seeking structured clarity
Patients with unclear or conflicting medical opinions who need an independent, evidence-based review
Patients considering regenerative or advanced therapies and needing a safety-first evaluation
Patients exploring clinical trial options and requiring eligibility screening and documentation support
Not sure which service fits your situation?
Answer 3 quick questions and we'll highlight the best fit.
Step 1 of 3
What best describes your situation?
This tool helps you navigate our services. It is not a medical assessment.
Founding Phase Professional Rates — Limited Until 31 December 2026
During the international expansion phase, a limited professional rate is available for a limited intake and may be adjusted in the future.
Start HereFounding Access Rate
Preliminary Case Orientation
€120€150
A structured entry-level advisory designed to provide clarity when uncertainty begins — before committing to a comprehensive review.
Secure medical document upload
Initial structured review of submitted records
30-minute video consultation OR concise written summary (PDF)
Clear guidance on next recommended steps
48–72 hour turnaround
Not a full multidisciplinary review. This service is professional orientation to reduce uncertainty and define direction.
Services & Fees
Multidisciplinary Case Review (Oncology & Complex Cases)
€240
Integrated review of pathology reports, imaging (CT / MRI / PET), laboratory findings, and treatment protocols.
A patient with advanced or recurrent cancer facing multiple treatment options and needing a structured comparison of approaches based on current evidence.
Delivered as: A structured, signed advisory memo (PDF).
Structured interpretation of advanced laboratory panels, including immune, inflammatory, angiogenic and neuro-immune markers, genomic panels and molecular profiling, and clinical proteomics tests performed in licensed laboratories.
Modeled on international molecular tumor board practices, adapted to individual cases and local treating teams.
Includes: Signed memo, clinical context, and targeted questions for the treating team.
Optional add-on: Memo + Video Explanation — €210
A patient has received complex biomarker or genomic test results and needs contextualized interpretation to guide treatment decisions with the local oncology team.
Surgical Complication & Treatment Review
€225
Independent evaluation of post-surgical complications, unexpected treatment responses, drug tolerance concerns, and protocol modifications.
Delivered as: Structured review memo (PDF).
Regenerative Medicine & Advanced Therapy Advisory
€240
Independent evaluation of emerging and advanced therapeutic strategies, including regenerative medicine approaches, cellular and protein-based therapies (research / advanced-care pathways), gene-editing technologies in research or clinical trial contexts, and personalized immune modulation concepts.
No therapeutic claims. No promises. Safety-first evaluation only.
A patient considering a commercial regenerative therapy or advanced treatment protocol and needs an independent, evidence-based assessment before proceeding.
Clinical Trial Matching & Eligibility Support
Level 1 — Trial Screening
€195
Targeted search + eligibility review + shortlist + gap list.
Level 2 — Trial-Ready Dossier Preparation
€425
Structured dossier aligned with trial requirements + submission-ready package.
Note: Trial acceptance is determined solely by trial sites.
You and your local team remain in full control. The advisory memo is a structured tool to support your decisions, not replace them.
Refund Policy
Cancel before review begins → Full refund
After review has started → Non-refundable
After memo delivery → Non-refundable
Clinical trial services → Non-refundable once screening begins
Provider cancellation → Full refund or reschedule
Frequently Asked Questions
Professional Advisory Notice
This is an independent scientific advisory service.
It does not replace direct medical care and is not an emergency service.
No direct prescriptions or medication adjustments are issued through this service.
Final clinical decisions remain with the treating physician/team.
Clinical trial eligibility and acceptance are determined solely by trial sites/research institutions.
All laboratory analyses are performed by independent, licensed clinical laboratories. Advisory interpretation is provided separately and does not constitute laboratory or diagnostic services.
Liability is limited to the fees paid for the requested service.